ABT · News · 20260814N
Revenue Performance and Mix
ABBOTT LABORATORIES · 2026-08-14 · Importance 37 · Surprise 6 · In source text
Abbott reported quarterly revenue of $12.59 billion, exceeding Wall Street expectations. The company also reported quarterly EPS of $1.31 alongside the revenue result. The reported earnings beat was attributed to strong quarterly performance across Abbott’s diversified business segments.
Key facts
- Abbott Laboratories reported quarterly earnings of $1.31 EPS and $12.59 billion in revenue. source
- Wolfe Research upgraded Abbott Laboratories (an upgrade from Wolfe Research was noted). source
- Institutional ownership of Abbott Laboratories is 75.18%. source
- Wall Street analysts maintain a "Moderate Buy" rating on Abbott Laboratories with an average price target of $118.67. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | unclear | realized | — | Abbott Laboratories reported quarterly earnings of $1.31 EPS and $12.59 billion in revenue. |
| net_income | unclear | realized | — | Abbott Laboratories reported quarterly earnings of $1.31 EPS and $12.59 billion in revenue. |